pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
637
stories
Sep 4, 26
Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
fiercebiotech
Sep 4, 26
Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains
stat
Sep 3, 26
American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of Sterility
fda recalls
Sep 3, 26
‘Tactical athletes’ get new guidance for cardiovascular fitness
stat
Sep 3, 26
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
fiercebiotech
Sep 3, 26
TScan cuts 75% of workforce while shifting focus to solid tumor program
biospace
Sep 3, 26
STAT+: Fauci speaks, and writes
stat
Sep 3, 26
SUPPLX.com Issues Voluntary Nationwide Recall of Business Pill and Branch Manager for Men Due to Undeclared Yohimbine
fda recalls
Sep 3, 26
AbbVie’s bispecific T-cell engager shows promise in ph. 3 multiple myeloma trial
fiercebiotech
Sep 3, 26
The pediatricians who take in vaccine-skeptical parents others won’t
stat
Sep 3, 26
B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter
fda medwatch
Sep 2, 26
Beyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical models
biospace
Sep 2, 26
TScan axes 75% of workforce to make room for solid tumor programs
fiercebiotech
Sep 2, 26
Catheter Recall Expansion: Medline Industries Removes Reprocessed Electrophysiology and Ultrasound Catheters
fda medwatch
Sep 1, 26
Mid-cap biotechs join Trump’s latest round of drug pricing deals
biopharma dive
Sep 1, 26
Paxlovid did not help long Covid, study finds
stat
Sep 1, 26
STAT+: Will House delay Trump plan to politicize NIH grants?
stat
Sep 1, 26
Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events
biospace
Sep 1, 26
ArsenalBio sheds most of staff in pivot to in vivo CAR-T
fiercebiotech
Sep 1, 26
Boston Scientific halts sales of angiographic catheters amid 2 serious injuries
fiercebiotech
Sep 1, 26
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused
endpoints
Aug 31, 26
STAT+: Trump strikes nine more deals with drugmakers to lower prices
stat
Aug 31, 26
UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies
fiercebiotech
Aug 31, 26
FDA OKs Takeda, Protagonist drug for rare blood cancer
biopharma dive
Aug 31, 26
ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsy
biopharma dive
Aug 31, 26
STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and more
stat
Aug 31, 26
STAT+: Can a pregnancy hormone steer a cardiovascular treatment?
stat
Aug 31, 26
Takeda, Protagonist score broad FDA nod in rare blood cancer, setting up $2B opportunity
biospace
Aug 31, 26
ESC26: AstraZeneca's heart failure drug shows promise in ph. 2 trial
fiercebiotech
Aug 31, 26
STAT+: Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy
stat
← prev
page 6 of 22
next →
